H3C14 and urinary bladder carcinoma: Loss of H3C14 enhances GCB resistance, promotes malignant phenotypes, reduces apoptosis and alters the expression of key GCB‐metabolizing enzymes, highlighting its potential as a therapeutic target in GCB‐refractory bladder cancer.